Literature DB >> 31227600

An Integrative Analysis of Tumor Proteomic and Phosphoproteomic Profiles to Examine the Relationships Between Kinase Activity and Phosphorylation.

Osama A Arshad1, Vincent Danna1, Vladislav A Petyuk1, Paul D Piehowski1, Tao Liu1, Karin D Rodland2, Jason E McDermott3.   

Abstract

Phosphorylation of proteins is a key way cells regulate function, both at the individual protein level and at the level of signaling pathways. Kinases are responsible for phosphorylation of substrates, generally on serine, threonine, or tyrosine residues. Though particular sequence patterns can be identified that dictate whether a residue will be phosphorylated by a specific kinase, these patterns are not highly predictive of phosphorylation. The availability of large scale proteomic and phosphoproteomic data sets generated using mass-spectrometry-based approaches provides an opportunity to study the important relationship between kinase activity, substrate specificity, and phosphorylation. In this study, we analyze relationships between protein abundance and phosphopeptide abundance across more than 150 tumor samples and show that phosphorylation at specific phosphosites is not well correlated with overall kinase abundance. However, individual kinases show a clear and statistically significant difference in correlation among known phosphosite targets for that kinase and randomly selected phosphosites. We further investigate relationships between phosphorylation of known activating or inhibitory sites on kinases and phosphorylation of their target phosphosites. Combined with motif-based analysis, this approach can predict novel kinase targets and show which subsets of a kinase's target repertoire are specifically active in one condition versus another.
© 2019 Arshad et al.

Entities:  

Keywords:  Breast cancer; Cancer Biology; Computational Biology; Ovarian cancer; Phosphoproteome; Phosphorylation; iTRAQ

Mesh:

Substances:

Year:  2019        PMID: 31227600      PMCID: PMC6692771          DOI: 10.1074/mcp.RA119.001540

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  44 in total

Review 1.  Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems.

Authors:  Tony Pawson
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.

Authors:  Matthew J Ellis; Michael Gillette; Steven A Carr; Amanda G Paulovich; Richard D Smith; Karin K Rodland; R Reid Townsend; Christopher Kinsinger; Mehdi Mesri; Henry Rodriguez; Daniel C Liebler
Journal:  Cancer Discov       Date:  2013-10       Impact factor: 39.397

Review 3.  Deregulation of cell signaling in cancer.

Authors:  Filippo G Giancotti
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

Review 4.  Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

Authors:  T Hunter
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

Review 5.  Physicochemical mechanisms of protein regulation by phosphorylation.

Authors:  Hafumi Nishi; Alexey Shaytan; Anna R Panchenko
Journal:  Front Genet       Date:  2014-08-07       Impact factor: 4.599

6.  Phosphoproteomics-Based Profiling of Kinase Activities in Cancer Cells.

Authors:  Jakob Wirbel; Pedro Cutillas; Julio Saez-Rodriguez
Journal:  Methods Mol Biol       Date:  2018

7.  Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.

Authors:  Mona M Hosseini; Stephen E Kurtz; Sherif Abdelhamed; Shawn Mahmood; Monika A Davare; Andy Kaempf; Johannes Elferich; Jason E McDermott; Tao Liu; Samuel H Payne; Ujwal Shinde; Karin D Rodland; Motomi Mori; Brian J Druker; Jack W Singer; Anupriya Agarwal
Journal:  Leukemia       Date:  2018-03-29       Impact factor: 11.528

8.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

9.  The Cytoprotective Effect of Hyperoside against Oxidative Stress Is Mediated by the Nrf2-ARE Signaling Pathway through GSK-3β Inactivation.

Authors:  Hai-Yan Xing; Yong-Qing Cai; Xian-Feng Wang; Lin-Li Wang; Pan Li; Guan-Ying Wang; Jian-Hong Chen
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

10.  Unraveling Kinase Activation Dynamics Using Kinase-Substrate Relationships from Temporal Large-Scale Phosphoproteomics Studies.

Authors:  Westa Domanova; James Krycer; Rima Chaudhuri; Pengyi Yang; Fatemeh Vafaee; Daniel Fazakerley; Sean Humphrey; David James; Zdenka Kuncic
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

View more
  10 in total

1.  Proteomics Is Not an Island: Multi-omics Integration Is the Key to Understanding Biological Systems.

Authors:  Bing Zhang; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2019-08-09       Impact factor: 5.911

2.  Proteomics for cancer drug design.

Authors:  Amanda Haymond; Justin B Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2019-08-04       Impact factor: 3.940

3.  Putting Humpty Dumpty Back Together Again: What Does Protein Quantification Mean in Bottom-Up Proteomics?

Authors:  Deanna L Plubell; Lukas Käll; Bobbie-Jo Webb-Robertson; Lisa M Bramer; Ashley Ives; Neil L Kelleher; Lloyd M Smith; Thomas J Montine; Christine C Wu; Michael J MacCoss
Journal:  J Proteome Res       Date:  2022-02-27       Impact factor: 4.466

4.  Functional Characterization of Co-Phosphorylation Networks.

Authors:  Marzieh Ayati; Serhan Yılmaz; Mark R Chance; Mehmet Koyuturk
Journal:  Bioinformatics       Date:  2022-06-22       Impact factor: 6.931

Review 5.  The active kinome: The modern view of how active protein kinase networks fit in biological research.

Authors:  Khaled Alganem; Abdul-Rizaq Hamoud; Justin F Creeden; Nicholas D Henkel; Ali S Imami; Alex W Joyce; William G Ryan V; Jacob B Rethman; Rammohan Shukla; Sinead M O'Donovan; Jarek Meller; Robert McCullumsmith
Journal:  Curr Opin Pharmacol       Date:  2021-12-27       Impact factor: 4.768

Review 6.  A Review of Imputation Strategies for Isobaric Labeling-Based Shotgun Proteomics.

Authors:  Lisa M Bramer; Jan Irvahn; Paul D Piehowski; Karin D Rodland; Bobbie-Jo M Webb-Robertson
Journal:  J Proteome Res       Date:  2020-09-25       Impact factor: 4.466

7.  leapR: An R Package for Multiomic Pathway Analysis.

Authors:  Vincent Danna; Hugh Mitchell; Lindsey Anderson; Iobani Godinez; Sara J C Gosline; Justin Teeguarden; Jason E McDermott
Journal:  J Proteome Res       Date:  2021-03-11       Impact factor: 4.466

8.  Robust inference of kinase activity using functional networks.

Authors:  Serhan Yılmaz; Marzieh Ayati; Daniela Schlatzer; A Ercüment Çiçek; Mark R Chance; Mehmet Koyutürk
Journal:  Nat Commun       Date:  2021-02-19       Impact factor: 17.694

9.  Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML.

Authors:  Sara J C Gosline; Cristina Tognon; Michael Nestor; Sunil Joshi; Rucha Modak; Alisa Damnernsawad; Camilo Posso; Jamie Moon; Joshua R Hansen; Chelsea Hutchinson-Bunch; James C Pino; Marina A Gritsenko; Karl K Weitz; Elie Traer; Jeffrey Tyner; Brian Druker; Anupriya Agarwal; Paul Piehowski; Jason E McDermott; Karin Rodland
Journal:  Clin Proteomics       Date:  2022-07-27       Impact factor: 5.000

10.  [Affinity chromatography based phosphoproteome research on lung cancer cells and its application].

Authors:  Baohui Zhang; Chentong Wang; Miao Guo; Hua Xiao
Journal:  Se Pu       Date:  2021-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.